Insider trades
Herriot Tabuteau, CEO of Axsome Therapeutics AXSM, has filed 0 purchases and 17 sales on the open market. Over the past 12 months that comes to a net sale of $80.8M. The latest trade was on 06/09.
Herriot Tabuteau
CEO
- Company
- Axsome Therapeutics AXSM
- First filing
- 23/03/06
- Trades
- 60 trades
- Buys / sales
- 0 / 17
- 12-month net buying
- −$80.8M
- Last trade
- 06/09
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/09 | 06/09 | 49,670 sh | $241.01 | $11,970,966.7 | −87.3% | |
| Open-market sale10b5-1 plan | 02/02 | 02/02 | 32,410 sh | $185.60 | $6,015,296 | −81.8% | |
AXSM | Open-market sale10b5-1 plan | 01/05–01/07 | 01/07 | 139,414 sh3 trades | $171.30avg. | $23,881,617.52 | −95.1% |
AXSM | Open-market sale10b5-1 plan | 25/12/02–25/12/04 | 25/12/04 | 79,973 sh3 trades | $145.66avg. | $11,648,582.34 | −91.7% |
AXSM | Open-market sale10b5-1 plan | 25/11/03–25/11/05 | 25/11/05 | 163,939 sh3 trades | $133.07avg. | $21,815,669.06 | −95.8% |
AXSM | Open-market sale10b5-1 plan | 25/10/06–25/10/08 | 25/10/08 | 45,384 sh3 trades | $119.38avg. | $5,418,059.86 | −86.3% |
AXSM | Open-market sale10b5-1 plan | 25/09/12–25/09/16 | 25/09/16 | 62,880 sh3 trades | $117.08avg. | $7,361,891.31 | −89.7% |